Covid-19 Vaccination Linked to Fewer Infections in Children with Eczema

New research presented at the 2025 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that Covid-19 vaccination may lower infection and allergy risks in children with atopic dermatitis (AD).

The retrospective cohort study compared 5,758 vaccinated and 5,758 unvaccinated AD patients under 17, matched for health history and demographics. Results showed that vaccinated children had significantly fewer respiratory and skin infections, including otitis media, pneumonia, and impetigo. They also had reduced risks of allergic conditions such as asthma, allergic rhinitis, and food-related anaphylaxis.

Researchers found a delayed onset of several infections and allergic reactions among vaccinated children. The findings suggest vaccination may slow the progression of atopic diseases, reinforcing both the safety and added health benefits of Covid-19 immunization for children with eczema.

10-11-2025